학술논문

836P Safety and efficacy of XMT-1536 in ovarian cancer: A subgroup analysis from the phase I expansion study of XMT-1536, a NaPi2b antibody-drug conjugate
Document Type
Abstract
Source
In Annals of Oncology September 2020 31 Supplement 4:S627-S628
Subject
Language
ISSN
0923-7534